$SIA (C6L.SG)$ buy and hold. sure will earn.

$SIA (C6L.SG)$ getting sadder with each passing moment

$SIA (C6L.SG)$ the lower it drop.. the sweeter it is when it rebound back.. not a share for short investment.  hold it till we fly again✈✈✈

$SIA (C6L.SG)$ up up up or down down down 😅😅will you buy if down?

$SIA (C6L.SG)$ Singapore Airlines is suitable for long-term investment. If capital is not used quickly and prepared for long-term investment, then its current price difference will actually not have much impact on long-term investment. The return should be good in the long run. As for when to enter the market, everyone has their own ideas.
However, if you expect Singapore Airlines stock to rise recently, it is unrealistic and probably very disappointing. Although the news of the launch of the VTL is good, the first flight had only 1/3 passengers, and if you don't fly, you may still lose money if you don't fly. Of course, having a flight is better than not flying. The downward pressure on Singapore Airlines in the short term should be huge. Expecting it to rise will definitely be disappointing. Singapore Airlines itself predicts that passenger traffic in the fourth quarter may return to 37% of what it was before the epidemic. Even if you think about it a little bit, you can understand that its next financial quarter will definitely not be good. How is it possible to rise ? If there is an increase, the fund must be rising. It is impossible for a long time, and stocks without performance support cannot actually rise.
In short, it is only when many countries around the world have slowly emerged from the COVID-19 pandemic and restarted. Probably when in 2022, Singapore Airlines will actually rise.

$CapitaLandInvest (9CI.SG)$ Knock Knock! Time to wake up

Asia stocks set to dip amid inflation
Asian stocks looked set to slip Tuesday on concerns about elevated inflation stoked by energy costs. The dollar held a climb.
Australian shares edged down, while futures for Japan and Hong Kong dipped. U.S. contracts retreated after the $S&P 500 Index (.SPX.US)$ and $NASDAQ 100 Index (.NDX.US)$ fell for a second day as the prospect of a slowing recovery from the pandemic shadowed trading.
Commodity surge fuels inflation threat
A surge in energy and metal prices is offering investors a fresh reminder of how the commodities market can fuel inflation and imperil the post-pandemic economic recovery.
The West Texas Intermediate crude price on Monday settled above $80 a barrel for the first time since 2014 while aluminum futures rose to their highest since July 2008, leading broad gains among base metals. In China, coal futures surged to a record.
Morgan Stanley sees stocks suffering on souring consumer outlook
Souring consumer confidence could soon catch up to stock market investors if this earnings season is clouded by downward guidance revisions.
Critically, the Fed and investors have embraced the view that inflation is transitory -- a view not shared by consumers. If consumer sentiment doesn’t quickly improve, it could be a signal of market weakness that would be sparked by disappointing earnings, weaker spending and higher savings rates.
Netflix to sell 'Squid Game' goods, other products on Walmart site
$Netflix (NFLX.US)$ is teaming up with $Walmart (WMT.US)$ to create a digital storefront on the retailer's website that will sell merchandise tied to hit shows such as "Stranger Things" and "Squid Game," the companies said.
The partnership is part of Netflix's broader strategy to develop new revenue streams beyond its core subscription business and market its content away from its own platform.
Apple decides its victory against Epic wasn't enough — it wants a total win
$Apple (AAPL.US)$ announced Friday night it would appeal a judge’s order forcing it to allow apps to link to alternative digital payment systems on the web. The move would protect Apples lucrative App Store model, which has come under fire from technology rivals, international regulators and members of the U.S. Congress. The appeal is at odds with Apple's original messaging that it was happy with the judges ruling in the case.
Merck asks FDA to authorize antiviral Covid pill for emergency use
$Merck & Co (MRK.US)$ said it asked the FDA to authorize emergency use of its experimental antiviral pill to treat mild to moderate Covid-19 in adults. Phase three clinical trial data showed that the drug – known as molnupiravir – reduced the chances that patients newly diagnosed with Covid would be hospitalized by about 50%. The experimental drug could be available to Americans by late this year.
Emerson plans to merge industrial-software businesses with AspenTech
$Emerson Electric (EMR.US)$ plans to merge two of its software businesses with $Aspen Technology (AZPN.US)$ in a roughly $11 billion deal aimed at capturing growing demand for industrial technology.
It is in general, as companies with surging stocks and ample cash look for deals that will boost growth and profitability. In the U.S., companies have struck more than $2 trillion of takeover deals so far in 2021, more than double the year-earlier pace, according to Dealogic.
US companies authorise more than $870bn in stock buybacks
Businesses have authorised more than $870bn of repurchases so far this year, Goldman Sachs data show, almost three times more than in the same period in 2020 and $50bn ahead of the record set in the first nine months of 2018. Record share repurchases in 2021 so far could signal optimism despite recent market dips.
Source: Bloomberg, WSJ, CNBC, Financial Times

$OCBC Bank (O39.SG)$ waiting

Covid has been in our lives for almost 2 years. We still can't travel around and hold parties like we used to. I wish for things to change every day before I sleep.
Although vaccines are not 100% effective, they have helped a lot. $Moderna (MRNA.US)$, $BioNTech (BNTX.US)$, $Pfizer (PFE.US)$and other vaccine makers have delivered tons of vaccines. MRNA and BNTX have gained around 200% this year. Did you catch the ride?
I see today that a Japanese drugmaker, called Shionogi, is developing easy-to-take Covid pills to combat mild cases. $Merck & Co (MRK.US)$ is also doing the same thing. But can they actually change the game?If so, will the drugs send Merck higher? Are you positive about such biotech companies and why?
Also, don't forget to check out the winners for 9.27-10.3!
Rewards calling! Comment to win rewards!
Moomoo news team and I hold the event together for a month! I will post discussions every day and Moomoo news team will support the event with reward points! We will pick the top 2 'liked' and top 3 'insightful' comments every weekday& top 10 'liked' and top 10 'insightful' comments every weekend to be the winners.
For more details, click here.
Follow me to join the latest discussion!